|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 89, 35-41, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
AJ Acinapura, JN Cunningham Jr, IJ Jacobowitz, DM Rose, MD Kramer, P Cappabianca, TH Elmquist and M Sanders
The use of percutaneous transluminal coronary angioplasty has been
increasing rapidly. When the procedure is successful, the clinical relief
of symptoms is similar to that achieved with direct coronary artery bypass.
It has been suggested that the angioplasty procedure, however, can
accomplish these results with potentially less morbidity and mortality,
along with a shorter hospital stay. In order to evaluate the results of
percutaneous transluminal coronary angioplasty with single-vessel coronary
artery bypass, we performed a retrospective review. From January, 1982, to
December, 1983, a total of 198 angioplasty procedures were performed. They
were successful in 142 patients (71.7%). Emergency bypass was performed in
21 (10.6%) of the 56 patients who had undergone unsuccessful angioplasty
procedures. Perioperative myocardial infarction occurred in eight of these
patients (38.1%). There were no operative deaths, but there was one death
after angioplasty. Elective bypass was performed in 28 of the patients who
had angioplasty procedures, with no perioperative myocardial infarctions or
operative deaths. Recurrent symptoms developed in 31 (21.8%) of the 142
patients who had undergone initially successful angioplasty. From 1982 to
1983, single-vessel bypass was performed in 143 patients. The internal
mammary artery was utilized in 102 patients and the autogenous saphenous
vein in 41 patients. There were no perioperative myocardial infarctions or
deaths. No patients developed recurrent symptoms during the study interval.
Percutaneous transluminal coronary angioplasty is an acceptable alternative
to coronary artery bypass in patients with localized lesions that are
sufficiently serious to cause symptoms and warrant surgical bypass.
However, the angioplasty procedure, when compared to single-vessel coronary
artery bypass, may result in an increased incidence of acute myocardial
infarction and in a significantly (p less than 0.001) increased incidence
of early recurrence of symptoms.
ARTICLES
Efficacy of percutaneous transluminal coronary angioplasty compared with single-vessel bypass
This article has been cited by other articles:
![]() |
T. M. Dewey and M. J. Mack Myocardial Revascularization Without Cardiopulmonary Bypass Card. Surg. Adult, January 1, 2003; 2(2003): 609 - 625. [Full Text] |
||||
![]() |
O. Tasdemir, K. M. Vural, H. Karagoz, and K. Bayazit Coronary artery bypass grafting on the beating heart without the use of extracorporeal circulation: review of 2052 cases J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 68 - 73. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |